Grønskov K, Vissing H, Shymko R M, Tornqvist H, De Meyts P
Hagedorn Research Institute, Gentofte, Denmark.
Biochem Biophys Res Commun. 1993 Apr 30;192(2):905-11. doi: 10.1006/bbrc.1993.1501.
We have investigated the role of Ser 85 and Arg 86 of the human insulin receptor (HIR) in insulin binding and tyrosine kinase activity by mutational analysis. Four mutant cDNAs were created (R86P, R86N, S85T+R86N, S85W+R86K) and stably transfected into BHK cells. R86P-HIR was also transiently expressed in 293 cells. Only the R86P receptor had substantially altered properties: lack of transport to the plasma membrane, loss of insulin binding, a constitutively activated autophosphorylation and tyrosine kinase, and an incomplete processing. Some of these alterations mimic those reported for the insulin receptor of the leprechaun Atl, which has a homozygous R86P mutation (Longo, N., et al, Biochem. Biophys. Res. Commun., 167, 1229, 1990; Clin. Res., 40, 2, 329, 1992).
我们通过突变分析研究了人胰岛素受体(HIR)的丝氨酸85和精氨酸86在胰岛素结合及酪氨酸激酶活性中的作用。构建了四个突变cDNA(R86P、R86N、S85T+R86N、S85W+R86K)并稳定转染至BHK细胞中。R86P-HIR也在293细胞中瞬时表达。只有R86P受体具有显著改变的特性:无法转运至质膜、丧失胰岛素结合能力、组成型激活的自身磷酸化和酪氨酸激酶,以及加工不完全。其中一些改变类似于报道的妖精貌综合征患者胰岛素受体的改变,该受体存在纯合R86P突变(Longo, N., 等人,《生物化学与生物物理研究通讯》,167, 1229, 1990;《临床研究》,40, 2, 329, 1992)。